XBOT Fundamental Analysis - REALBOTIX CORP

Fundamental Rating

Taking everything into account, XBOT scores 3 out of 10 in our fundamental rating. XBOT was compared to 21 industry peers in the Machinery industry. XBOT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XBOT is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year XBOT has reported negative net income.

In the past year XBOT has reported a negative cash flow from operations.

XBOT had negative earnings in 4 of the past 5 years.

In the past 5 years XBOT always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -213.45%, XBOT is not doing good in the industry: 90.48% of the companies in the same industry are doing better.

The Return On Equity of XBOT (-333.51%) is worse than 80.95% of its industry peers.

		Industry Rank	Sector Rank
ROA	-213.45%
ROE	-333.51%
ROIC	N/A

ROA(3y)-62.89%

ROA(5y)-29.3%

ROE(3y)-84.55%

ROE(5y)-42.13%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of XBOT (36.47%) is better than 76.19% of its industry peers.

XBOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.47%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XBOT does not have a ROIC to compare to the WACC, probably because it is not profitable.

XBOT has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, XBOT has more shares outstanding

Compared to 1 year ago, XBOT has a worse debt to assets ratio.

2.2 Solvency

XBOT has an Altman-Z score of 5.44. This indicates that XBOT is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 5.44, XBOT belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.

A Debt/Equity ratio of 0.22 indicates that XBOT is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.22, XBOT is doing good in the industry, outperforming 66.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Altman-Z	5.44

ROIC/WACCN/A

WACC8.47%

2.3 Liquidity

A Current Ratio of 1.47 indicates that XBOT should not have too much problems paying its short term obligations.

XBOT has a Current ratio (1.47) which is comparable to the rest of the industry.

A Quick Ratio of 1.32 indicates that XBOT should not have too much problems paying its short term obligations.

With a decent Quick ratio value of 1.32, XBOT is doing good in the industry, outperforming 76.19% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.47
Quick Ratio	1.32

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

XBOT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2795834648671604224.00%.

XBOT shows a strong growth in Revenue. In the last year, the Revenue has grown by 182.51%.

EPS 1Y (TTM)-2795834648671604000%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)182.51%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%97.12%

3.2 Future

The Earnings Per Share is expected to grow by 48.39% on average over the next years. This is a very strong growth

XBOT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 165.68% yearly.

EPS Next Y39.4%

EPS Next 2Y48.39%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year76.47%

Revenue Next 2Y165.68%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 27.99, the valuation of XBOT can be described as expensive.

The rest of the industry has a similar Price/Forward Earnings ratio as XBOT.

XBOT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.01.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.99

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

XBOT's earnings are expected to grow with 48.39% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y48.39%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for XBOT!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

REALBOTIX CORP

TSX-V:XBOT (12/22/2025, 7:00:00 PM)

0.39

+0.05 (+13.04%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)08-14 2025-08-14/bmo

Earnings (Next)01-26 2026-01-26

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners38.61%

Ins Owner ChangeN/A

Market Cap84.33M

Revenue(TTM)2.75M

Net Income(TTM)-15.99M

Analysts80

Price Target0.71 (82.05%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-32.96%

Min Revenue beat(2)-42.04%

Max Revenue beat(2)-23.89%

Revenue beat(4)0

Avg Revenue beat(4)-32.45%

Min Revenue beat(4)-48.84%

Max Revenue beat(4)-15.02%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.99
P/S	22.21
P/FCF	N/A
P/OCF	N/A
P/B	12.75
P/tB	16.83
EV/EBITDA	N/A

EPS(TTM)-0.13

EYN/A

EPS(NY)0.01

Fwd EY3.57%

FCF(TTM)-0.03

FCFYN/A

OCF(TTM)-0.03

OCFYN/A

SpS0.02

BVpS0.03

TBVpS0.02

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-213.45%
ROE	-333.51%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	36.47%
FCFM	N/A

ROA(3y)-62.89%

ROA(5y)-29.3%

ROE(3y)-84.55%

ROE(5y)-42.13%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.47
Quick Ratio	1.32
Altman-Z	5.44

F-Score3

WACC8.47%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-2795834648671604000%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next Y39.4%

EPS Next 2Y48.39%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)182.51%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%97.12%

Revenue Next Year76.47%

Revenue Next 2Y165.68%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-58.52%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-5025.27%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-4811.87%

OCF growth 3YN/A

OCF growth 5YN/A

REALBOTIX CORP / XBOT.CA FAQ

Can you provide the ChartMill fundamental rating for REALBOTIX CORP?

ChartMill assigns a fundamental rating of 3 / 10 to XBOT.CA.

Can you provide the valuation status for REALBOTIX CORP?

ChartMill assigns a valuation rating of 2 / 10 to REALBOTIX CORP (XBOT.CA). This can be considered as Overvalued.

How profitable is REALBOTIX CORP (XBOT.CA) stock?

REALBOTIX CORP (XBOT.CA) has a profitability rating of 1 / 10.

What is the expected EPS growth for REALBOTIX CORP (XBOT.CA) stock?

The Earnings per Share (EPS) of REALBOTIX CORP (XBOT.CA) is expected to grow by 39.4% in the next year.

REALBOTIX CORP (XBOT.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

REALBOTIX CORP / XBOT.CA FAQ

Can you provide the ChartMill fundamental rating for REALBOTIX CORP?

Can you provide the valuation status for REALBOTIX CORP?

How profitable is REALBOTIX CORP (XBOT.CA) stock?

What is the expected EPS growth for REALBOTIX CORP (XBOT.CA) stock?